American Journal of Obstetrics & Gynecology
Volume 198, Issue 1 , Pages 28.e1-28.e5 , January 2008

How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?

  • Manfredi Rizzo, MD, PhD

      Affiliations

    • Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
    • Corresponding Author InformationReprints: Manfredi Rizzo, MD, PhD, Dipartimento di Medicina Clinica e delle Patologie Emergenti, Universita’ di Palermo, Via del Vespro, 141, 90127 Palermo, Italy.
    • ,
  • Kaspar Berneis, MD

      Affiliations

    • Division of Endocrinology and Diabetology, University Hospital, Zurich, Switzerland.
    • ,
  • Enrico Carmina, MD

      Affiliations

    • Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
    • ,
  • Giovam Battista Rini, MD

      Affiliations

    • Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo, Italy

Received 7 May 2007 ,Revised 3 September 2007 ,Accepted 8 September 2007.

  • Image Result

    Atherogenic lipoprotein phenotype (ALP), LDL heterogeneity, and plasma triglyceride and HDL-cholesterol concentrations

    The atherogenic lipoprotein phenotype (ALP), LDL heterogeneity and plasma triglyce

    Atherogenic lipoprotein phenotype (ALP), LDL heterogeneity, and plasma triglyceride and HDL-cholesterol concentrations

    The atherogenic lipoprotein phenotype (ALP), LDL heterogeneity and plasma triglyceride and HDL-cholesterol concentrations.

    Modified from Griffin BA, Caslake MJ, Yip B, et al. Atherosclerosis 1990;83:59-67.

  • Image Result
    Prevalence of complete and incomplete forms of atherogenic lipoprotein phenotype (ALP) in patients with PCOSModified from Griffin BA, Caslake MJ, Yip B, et al. Atherosclerosis 1990;83:59-67.

    Prevalence of complete and incomplete forms of atherogenic lipoprotein phenotype (ALP) in patients with PCOS

    Modified from Griffin BA, Caslake MJ, Yip B, et al. Atherosclerosis 1990;83:59-67.

 Cite this article as: Rizzo M, Berneis K, Carmina E, et al. How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? Am J Obstet Gynecol 2008;198:28.e1-28.e5.

PII: S0002-9378(07)01113-1

doi: 10.1016/j.ajog.2007.09.014

American Journal of Obstetrics & Gynecology
Volume 198, Issue 1 , Pages 28.e1-28.e5 , January 2008

Article Tools

* Image Usage & Resolution